Clash Over Abortion Hobbles A Health Bill. Again. Here’s How.
As Congress considers a bipartisan bill to help hold down premium prices on the health law’s marketplaces, a long-standing fight over abortion reappears.
The independent source for health policy research, polling, and news.
6,981 - 7,000 of 15,457 Results
As Congress considers a bipartisan bill to help hold down premium prices on the health law’s marketplaces, a long-standing fight over abortion reappears.
Scientists are finding that, just as with secondhand smoke from tobacco, inhaling secondhand smoke from marijuana can make it harder for arteries to expand to allow a healthy flow of blood.
Federal health officials recommend that adults get a number of vaccinations, including protections against shingles, the flu, pneumonia, tetanus, diphtheria and pertussis. But immunization rates are generally low.
Lawsuits and complaints about sexual harassment are piling up in the health care industry as women take on doctors, peers and co-workers.
President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.
The state’s ambitious payment overhaul has begun to demonstrate savings and a change in culture, say new reports.
California's legislature will soon take up a bill that would require doctors to screen pregnant women and new mothers for mental health problems. Many doctors oppose the idea, and laws elsewhere haven't increased the number of moms treated.
More than a dozen Republicans in the Virginia House of Delegates voted to expand Medicaid, and at least one state senator may be leaning in favor of expansion. It will be the hot topic as legislators are called back to Richmond to hash out a budget in the special session starting April 11.
How a prescription wiped out one woman’s health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don’t) with medical costs.
A nationwide shortage of injectable opioid painkillers has left hospitals scrambling to find alternatives — in some cases leading to dosage mistakes that may harm patients.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post discuss the problems that are making congressional efforts to pass legislation to stabilize the individual insurance market a long shot.
In a historic move, the Food and Drug Administration stated its intent Thursday to require tobacco companies to cut nicotine levels in their products to make them less addictive. Stripping cigarettes of addictive power could lead an estimated 5 million adults to quit smoking within a year of the plan.
A national survey finds that medical schools should do more to help doctors with disabilities thrive. Although some schools do make needed accommodations, others need to take basic steps to help.
Starting in April, new Medicare cards will be issued to the program’s 59 million enrollees. The new cards address serious security concerns, yet there are growing “scams” linked to the rollout.
The pill, known as PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years — but primarily among a white demographic.
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it — or at least salvage its own reputation.
The research, focused on Los Angeles County, casts a positive light on a 2004 initiative that expanded mental health services statewide. A recent state audit, however, suggested hundreds of millions of dollars from the initiative were piling up, left unspent by counties.
Last month’s budget deal means Medicare beneficiaries are eligible for physical and occupational therapy indefinitely. Plus, prescription drug costs will fall for more seniors.
Three participants in unauthorized herpes vaccine research file a lawsuit against scientist’s company, alleging adverse side effects.
Researchers at the University of Southern California analyzed millions of prescriptions and concluded that close to a quarter paid copays that exceeded the cost of the drugs.
© 2026 KFF